EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›ASRV

ASRV

AMERISERV FINANCIAL INC /PA/

Next earnings Jul 20, 2026

Last earnings +0.8% on 2026-04-21

Hold
$3.86▲ +33.95%
over 1Y
L $2.70EODHDH $4.01
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today—
1W+2.7%
1M+1.3%
3M+7.4%
YTD+19.7%
1Y+33.9%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
B
Valuation
Undervalued
Filings
Clean
Hold
Conviction
Horizon
Long (>12mo)
12-mo target
$•••

Cheap PA community bank at ~0.53x book with recovering earnings, but a sub-5% ROE keeps it a value-trap risk.

Book value per share $7.22 · FY2025

The read

Middling fundamentals offset by an attractive price (~235% below fair value) — worth a look on the value angle.

AmeriServ is a $1.45B-asset Pennsylvania community bank whose stock case is about book value, not the income statement. The provided P/S of 4.5x is misleading: the $14.6M 'revenue' tag captures only a sliver of the bank's economics — the MD&A shows total interest income of $71.4M, net interest income of $42.3M (up $6.2M YoY) and non-interest income of $17.0M. The number that matters is book value per share of $7.22 (tangible $6.39) against a $3.86 price — roughly 0.53x book / 0.60x tangible book. That is a steep discount, and it exists for a reason: return on average equity was only 5.03% and ROAA just 0.39% in 2025, below the bank's cost of capital, which is precisely why the market won't pay book.

The operating trend is genuinely improving. Net income rose 55.8% to $5.61M ($0.34 diluted EPS, up from $0.21), driven by a 34-bp expansion in net interest margin to 3.15% from 'effective balance sheet management,' even while the bank absorbed a higher $4.12M credit-loss provision to bring 'final resolution to its largest non-performing loan.' Credit quality is healing — non-performing loans fell to 0.80% of loans from 1.02%, and non-interest expense was held roughly flat at $48.3M. Book value per share grew 11.2% and equity rose to $119M. The 2023 loss ($3.35M) tied to the Rite Aid bankruptcy's hit on CRE collateral is now two years in the rear-view.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$15.0M$14.7M$14.5M$15.6M$14.6M
Gross profit—————
Operating income—————
Net income$7.07M$7.45M-$3.35M$3.60M$5.61M
Diluted EPS$0.41$0.43-$0.20$0.21$0.34
Net margin47.2%50.5%-23.1%23.1%38.3%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt$14.6M
Net cash$36.2M
Piotroski F-Score3/6

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+2.7%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has been improving.
  1. DEF 14A Proxy statement2026-06-08

    Routine annual-meeting proxy: director slate, auditor ratification, exec comp vote

  2. 8-K Officer / director change2026-05-27

    Announced a director/officer change (Item 5.02) plus a Reg FD update; no financial impact disclosed

  3. 10-Q Quarterly report2026-05-14

    Q1 2026 (period 3/31): continued the post-2023 recovery with positive earnings

  4. 8-K Earnings results2026-04-21

    Released Q1 2026 results, extending the 2025 earnings-recovery and margin-expansion trend

  5. 10-K Annual report2026-03-18

    FY2025: NII +$6.2M, NIM +34bps, book value +11.2% to $7.22 despite higher loan provision

  6. 8-K Officer / director change2026-03-04

    Reported a board/management change (Item 5.02); no earnings or financial detail

  7. 8-K Earnings results2026-01-20

    FY2025 results: net income $5.6M (+56%), EPS $0.34, NIM up 34bps to 3.15%

  8. 8-K Material agreement2026-01-07

    Entered a material agreement and sold unregistered shares (Item 3.02) — modest dilution risk

  9. 10-Q Quarterly report2025-11-13

    Q3 2025 interim results consistent with the year's margin-driven earnings improvement

Recent filings

all on EDGAR ↗
11-KPeriod ending 2025-12-312026-06-23open ↗DEF 14APeriod ending 2026-07-232026-06-08open ↗ARSPeriod ending 2025-12-312026-06-08open ↗4Period ending 2026-06-022026-06-03open ↗4Period ending 2026-06-022026-06-03open ↗4Period ending 2026-06-022026-06-03open ↗4Period ending 2026-06-022026-06-03open ↗4Period ending 2026-06-022026-06-03open ↗4Period ending 2026-06-022026-06-03open ↗4Period ending 2026-06-022026-06-03open ↗4Period ending 2026-05-182026-06-01open ↗4Period ending 2026-05-182026-06-01open ↗

Quality score

B
ValueGrowthProfitHealthMom.
Value—
GrowthB-
ProfitabilityB+
Financial healthA-
Momentum—
  • ✗Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✗Return on equity above 15%

Fair value est.

$12.92

Undervalued +235% vs last close

cheapfair valueexpensive

Modified Graham: EPS $0.34 × (8.5 + 1.5 × 22.0% growth) × 0.95 quality = 38.0× multiple. An estimate, not a price target.

Revenue
$14.6M
-6.3% YoY
Net margin
38.3%
ROE
4.7%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$14.6M-6.3%
Net income$5.61M+55.8%
Diluted EPS$0.34+61.9%
Cash & equivalents$50.9M+186.8%
Total assets$1.45B+2.2%
Total liabilities$1.33B+1.5%
Stockholders' equity$119M+11.2%
L/E: 11.18x

Frequently asked

Is AMERISERV FINANCIAL INC /PA/ (ASRV) a buy?
ASRV currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Cheap PA community bank at ~0.53x book with recovering earnings, but a sub-5% ROE keeps it a value-trap risk.
What is ASRV's fair value?
A Modified-Graham model based on ASRV's SEC fundamentals estimates a fair value of about $12.92. It is an estimate from reported earnings, not a price target.
Is ASRV overvalued or undervalued?
Against a Modified-Graham fair-value estimate, ASRV currently appears undervalued relative to its SEC-grounded earnings power.
What is AMERISERV FINANCIAL INC /PA/'s quality score?
ASRV scores 73.46153846153845/100 (grade B) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000707605, latest 10-Q filed 2026-05-14) · analysis by claude-code · as of 6/30/2026, 1:07:30 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-06-02
ADAMS J MICHAEL JR
Director
Award7.25K @ $3.79$27.5K
2026-06-02
Bloomingdale Richard W.
Director
Award7.25K @ $3.79$27.5K
2026-06-02
Bradley Amy
Director
Award7.25K @ $3.79$27.5K
2026-06-02
Hickton David J.
Director
Award7.25K @ $3.79$27.5K
2026-06-02
KUNKLE KIM W
Director
Award7.25K @ $3.79$27.5K
2026-06-02
Onorato Daniel A.
Director
Award7.25K @ $3.79$27.5K
2026-06-02
PASQUERILLA MARK E
Director
Award7.25K @ $3.79$27.5K
2026-05-18
Onorato Daniel A.
Director
Award434.00 @ $3.92$1.70K

Earnings history

beat/miss · move
2026-04-21—▼ -2.72%8-K ↗
2026-01-20—▲ +1.90%8-K ↗
2025-10-21—▲ +6.34%8-K ↗
2025-07-22—▼ -2.54%8-K ↗
2025-04-22—▲ +8.33%8-K ↗
2025-01-21—▲ +1.51%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Vs tracked universe

compare →

1192 tracked peers · median

EDGAR Score73 vs 67
Revenue growth-6.3% vs 7.5%
Net margin38.3% vs 10.0%
Return on equity4.7% vs 12.0%
P/E— vs 25.7